Is ResMed encroaching on F&P Healthcare's market share?
The close competitors don't like to give away market share but analysts delve deeper.
Medical device maker Fisher & Paykel Healthcare [NZX: FPH] looks to be holding strong against its main competitor for mask market share although its flow generator share has declined – but analysts have to keep a close watch to make sure.
East Tamaki-based F&P, which manufactures health products
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Mon, 02 May 2016
Mon, 02 May 2016
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Related News
Related News
Is ResMed encroaching on F&P Healthcare's market share?
57740